MARKET NEWS

Quotient Sciences & CytoAgents Accelerate Potential Treatment for COVID-19 Cytokine Storm
Avadel Pharmaceuticals Announces Positive Topline Results from its Pivotal Phase 3 REST-ON Trial
Amphastar Pharmaceuticals Receives FDA Approval for Epinephrine Injection
Orchard Therapeutics Announces First Patient Dosed with OTL-201 Gene Therapy 
Harpoon Therapeutics Doses First Patient with HPN217, a BCMA Targeting TriTAC, for Multiple Myeloma
BioAegis Demonstrates Gelsolin Therapy Can Quell the COVID-19 Cytokine Storm & Promote Tissue Repair
Santhera & Cold Spring Harbor Laboratory to Investigate Lonodelestat  in COVID-19-Related ARDS

  FEATURED EDITORIAL

  COMPANY PROFILE

Credence MedSystems is setting a new standard in drug delivery, helping you differentiate your products through innovative delivery systems while preserving your trusted processes. Simple, safe, and intuitive usability creates a better, safer experience for patients and healthcare professionals. Innovative designs provide safety activation clicks, end-of-dose feedback cues, and automatic needle retraction — without changes to familiar injection procedures. Our unique product innovations coexist with your existing processes, avoiding disruption to your filling lines and simplifying your secondary packaging operations. Use the primary container and components of your choice. Maintain your preferred sourcing strategy and manufacturing processes. Click here for more.

  EXCLUSIVE ONLINE CONTENT

WEBINAR - Developing an Oral Modified-Release (MR) Formulation: Challenges & Considerations for Achieving Success

WEBINAR - Developing an Oral Modified-Release (MR) Formulation: Challenges & Considerations for Achieving Success

Please join Quotient Sciences’ Vice President of Pharmaceutical Sciences, Dr. Andy Lewis, on May 20 at 10 AM London/11 AM Brussels or 6 PM London/1 PM New York for a live webinar on modified-release formulation…

Mitsubishi Chemical to Bolster Technology Platform Through Acquisition of American Organic & Inorganic Hybrid Chemicals

Mitsubishi Chemical to Bolster Technology Platform Through Acquisition of American Organic & Inorganic Hybrid Chemicals

Mitsubishi Chemical Corporation recently announced its subsidiary Mitsubishi Chemical America, Inc. has entered into a definitive agreement to acquire all of the issued and….

Trio Pharmaceuticals & Ajinomoto Bio-Pharma Services Enter Development Collaboration for a Novel Antibody Therapeutic

Trio Pharmaceuticals & Ajinomoto Bio-Pharma Services Enter Development Collaboration for a Novel Antibody Therapeutic

Trio Pharmaceuticals, Inc. and Ajinomoto Bio-Pharma Services recently announced a development collaboration agreement to evaluate AJICAP, a proprietary site-specific conjugation technology offered by…

Stevanato Group Announces Product Development Collaboration With Cambridge Design Partnership on Pen-Injector Technology

Stevanato Group Announces Product Development Collaboration With Cambridge Design Partnership on Pen-Injector Technology

Stevanato Group, a  leading producer of glass primary packaging and provider of integrated capabilities for combination products and Cambridge Design Partnership (CDP), a UK- and US-based leading technology and product design partner, recently….

Catalent Signs Agreement With Johnson & Johnson to be US Manufacturing Partner for Lead COVID-19 Vaccine Candidate

Catalent Signs Agreement With Johnson & Johnson to be US Manufacturing Partner for Lead COVID-19 Vaccine Candidate

Catalent, Inc. recently announced a collaboration with the Janssen Pharmaceutical Companies of Johnson & Johnson, whereby Catalent’s Biologics business unit will accelerate availability of manufacturing capacity and…

PharmaCircle’s COVID-19 Coverage is Available to Everyone

PharmaCircle’s COVID-19 Coverage is Available to Everyone

Updated daily, coverage includes top line epidemiology, the current active pipeline, vaccine development, diagnostic tests, recent news and clinical trials.

Pivotal to Provide Specialized Clinical Research Services for New Clinical Trial With Patients That Have COVID-19

Pivotal to Provide Specialized Clinical Research Services for New Clinical Trial With Patients That Have COVID-19

Pivotal recently announced it has been contracted to provide specialized clinical research services in a clinical trial to study the efficacy and safety of hyperimmune plasma, obtained from…

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

May 13 – Particle Design Technology
May 20 – Nasal Drug Delivery